Company news

Futura Medical plc news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Application to the US FDA for MED3000

October 3, 2022

PDMR Dealing and Total Voting Rights

September 16, 2022

Futura Medical Interim Results 2022

September 13, 2022

Notice of Interim Results

September 1, 2022

Highly positive FM71 Phase 3 Study Results

August 31, 2022

Price Monitoring Extension

July 12, 2022

Futura Medical AGM Results

June 28, 2022

Notice of AGM and Availability of Annual Report

June 1, 2022

Agreement with Cooper Consumer Health - Correction

May 23, 2022

Full Year Results 2021

April 26, 2022

Futura Medical Notice of Preliminary Results 2021

April 14, 2022

Futura Announces Collaboration with Menarini

March 23, 2022

TR-1: Notification of major holdings

February 2, 2022

Remuneration of Non-Executive Directors and TVR

January 13, 2022

US regulatory and commercial update for MED3000

December 20, 2021

Futura Medical plc Total Voting Rights

November 30, 2021

Futura Medical plc Board Appointment

October 28, 2021

Director/PDMR Shareholding

October 5, 2021

Interim Results for Six Months ended 30 June 2021

September 29, 2021

Futura Announces Collaboration with Labatec Pharma

September 27, 2021

First Patient visit in MED3000 Confirmatory Study

September 15, 2021

TR1: Notification of Major Holdings

September 8, 2021

Futura Medical Announces Collaboration of MED3000

August 31, 2021

FDA regulatory and commercial update for MED3000

July 19, 2021

Notice of AGM and Annual Report

June 3, 2021

Result of General Meeting & Total Voting Rights

June 2, 2021

Posting of Circular and Notice of General Meeting

May 17, 2021

Retail Offer by PrimaryBid

May 14, 2021

Futura Receives Approval from EU Notified Body

April 30, 2021

Correction - Conversion of Convertible Loan Notes

April 19, 2021

Conversion of Convertible Loan Notes

April 15, 2021

Full Year Results for the year ended 31 Dec 2020

April 14, 2021

Exercise of Warrants, Issue of Equity & TVR

April 1, 2021

US FDA Agreement for Confirmatory Clinical study

March 22, 2021

Futura Receives Recommendation for Approval

March 19, 2021

Futura Announces Investment & Joint Collaboration

March 4, 2021

Futura provides US regulatory & commercial update

December 8, 2020

Futura provides regulatory and commercial update

October 22, 2020

Interim Results for Six Months ended 30 June 2020

September 16, 2020

Futura receives positive QMS Audit Opinion

August 10, 2020

Futura update on CBD100 1st Stage Development Work

August 4, 2020

Futura Medical provides EU & US regulatory update

July 14, 2020

Block listing Interim Review - Replacement

July 10, 2020

Trading Statement

June 24, 2020

Block listing Interim Review

June 1, 2020

Futura files for Further Pre-Submission meeting

April 20, 2020

Futura Confirms Receipt of US FDA Minutes

April 6, 2020

Full Year Results for the year ended 31 Dec 2019

April 1, 2020

Futura to Update on MED3000 at Investor Seminar

March 5, 2020

Update on positive EU regulatory discussions

February 13, 2020

← Newer news releases · Older news releases →

Calls

The 5 newest of 12 calls. Every call is listed under its year.

Decks